Recent molecular insights from mutated IKS channels in cardiac arrhythmia.

Meidan Dvir, Asher Peretz, Yoni Haitin, Bernard Attali

Journal: Current opinion in pharmacology 2014;15():74-82

PMID: 24721657

Abstract

Co-assembly of KCNQ1 with KCNE1 generates the IKS potassium current that is vital for the proper repolarization of the cardiac action potential. Mutations in either KCNQ1 or KCNE1 genes lead to life-threatening cardiac arrhythmias causing long QT syndrome, short QT syndrome, sinus bradycardia and atrial fibrillation. Findings emerging from recent studies are beginning to provide a picture of how gain-of-function and loss-of-function mutations are associated with pleiotropic cardiac phenotypes in the clinics. In this review, we discuss recent molecular insights obtained from mutations altering different structural modules of the channel complex that are essential for proper IKS function. We present the possible molecular mechanisms underlying mutations impairing the voltage sensing functions, as well as those altering the channel regulation by phosphatidylinositol-4,5-bisphosphate, calmodulin and protein kinase A. We also discuss the significance of diseased IKS channels for adequate pharmacological targeting of cardiac arrhythmias.

Copyright © 2013 Elsevier Ltd. All rights reserved.

Address: Department of Physiology & Pharmacology, The Sackler Faculty of Medicine, Tel Aviv University, 69978 Tel Aviv, Israel.; Department of Physiology & Pharmacology, The Sackler Faculty of Medicine, Tel Aviv University, 69978 Tel Aviv, Israel. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.